DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 190 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,947,528 | -6.4% | 2,704,917 | -28.9% | 1.36% | -17.7% |
| Q1 2023 | $37,330,680 | -7.8% | 3,805,370 | 0.0% | 1.65% | +13.7% |
| Q4 2022 | $40,489,137 | +1.9% | 3,805,370 | 0.0% | 1.45% | +0.9% |
| Q3 2022 | $39,728,000 | -17.1% | 3,805,370 | 0.0% | 1.44% | -21.4% |
| Q2 2022 | $47,910,000 | +16.1% | 3,805,370 | 0.0% | 1.83% | +18.5% |
| Q1 2022 | $41,250,000 | -23.0% | 3,805,370 | 0.0% | 1.54% | -15.4% |
| Q4 2021 | $53,542,000 | -15.1% | 3,805,370 | +15.9% | 1.82% | -1.7% |
| Q3 2021 | $63,077,000 | +114.1% | 3,283,570 | +9.8% | 1.86% | +101.0% |
| Q2 2021 | $29,459,000 | -14.1% | 2,990,770 | -14.3% | 0.92% | -11.9% |
| Q1 2021 | $34,314,000 | +162.5% | 3,490,770 | +18.9% | 1.05% | +127.8% |
| Q4 2020 | $13,070,000 | +3.0% | 2,936,990 | 0.0% | 0.46% | -21.6% |
| Q3 2020 | $12,688,000 | +25.1% | 2,936,990 | +156.8% | 0.59% | +11.6% |
| Q2 2020 | $10,143,000 | – | 1,143,526 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |